The Enterprise Value as of December 2025 (TTM) for Orient Pharma Co., Ltd. (4166.TWO) is 5.20B

According to Orient Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.20B. This represents a change of -32.65% compared to the average of 7.72B of the last 4 quarters.

Orient Pharma Co., Ltd. (4166.TWO) Historical Enterprise Value (quarterly & annually)

How has 4166.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Orient Pharma Co., Ltd. over the last ten years is 4.50B. The current 5.20B Enterprise Value has changed 11.44% with respect to the historical average. Over the past ten years (40 quarters), 4166.TWO's Enterprise Value was at its highest in in the June 2025 quarter at 8.90B. The Enterprise Value was at its lowest in in the December 2022 quarter at 4.33B.

Orient Pharma Co., Ltd. (4166.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Orient Pharma Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Orient Pharma Co., Ltd. (4166.TWO) Average Enterprise Value

How has 4166.TWO Enterprise Value performed in the past?

The current Enterprise Value of Orient Pharma Co., Ltd. (4166.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Orient Pharma Co., Ltd. (4166.TWO) Enterprise Value vs. Peers

How is 4166.TWO’s Enterprise Value compared to its peers?

Orient Pharma Co., Ltd.’s Enterprise Value is less than Panion & Bf Biotech Inc. (5.85B), greater than BIONET Corp. (4.95B), greater than Easywell Biomedicals, Inc. (4.47B), less than SCI Pharmtech, Inc. (6.69B), less than Formosa Optical Technology Co.,Ltd. (9.73B), greater than Brighten Optix Corporation (5.02B), less than Ever Fortune.AI Co., Ltd. (5.96B), less than Hi-Clearance Inc. (6.82B), greater than Savior Lifetec Corporation (4.57B), less than Orient EuroPharma Co., Ltd. (5.46B),

Build a custom stock screener for Orient Pharma Co., Ltd. (4166.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orient Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Orient Pharma Co., Ltd. (4166.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Orient Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.